Literature DB >> 26811242

[Sexuality in overweight and obesity].

Heidemarie Abrahamian1, Alexandra Kautzky-Willer2.   

Abstract

The association between obesity and sexual dysfunction has been described in many studies. Neurobiological, hormonal, vascular and mental disturbances are the main reasons in male and in female gender. Sexual interest and desire, sexual arousal, orgasm, painful intercourse and premature ejaculation can be involved. Data for prevalence of sexual function disturbances in obese people are scarce and most studies were small. For screening of sexual function we recommend the International Index of Erectile Function (IIEF)-Score, which contains 15 Items for males and the Female Sexual Function Index (FSFI), which contains 19 items for females. Treatment of sexual function disturbances include lifestyle changes with an increase of physical activity, weight control, healthy eating and smoking cessation. Testosterone substitution in cases of real hypogonadism and treatment with PDE-5 inhibitors are well documented treatment options in male individuals. New treatment options for female patients with variable effectiveness are fibanserin, testosterone, bupropione and oxytocin.

Entities:  

Keywords:  Female Sexual Function Index (FSFI); Hypogonadism; International Index of Erectile Function-5 (IIEF5); Obesity; Sexual dysfunction

Mesh:

Year:  2016        PMID: 26811242     DOI: 10.1007/s10354-016-0430-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  46 in total

Review 1.  Clinical practice. Sexual desire and arousal disorders in women.

Authors:  Rosemary Basson
Journal:  N Engl J Med       Date:  2006-04-06       Impact factor: 91.245

2.  Association of body weight with sexual function in women.

Authors:  K Esposito; M Ciotola; F Giugliano; C Bisogni; B Schisano; R Autorino; L Cobellis; M De Sio; N Colacurci; D Giugliano
Journal:  Int J Impot Res       Date:  2007-02-08       Impact factor: 2.896

3.  Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial.

Authors:  Dana A Muin; Michael Wolzt; Rodrig Marculescu; Safoura Sheikh Rezaei; Mohamed Salama; Carola Fuchs; Anton Luger; Elia Bragagna; Brigitte Litschauer; Michaela Bayerle-Eder
Journal:  Fertil Steril       Date:  2015-07-04       Impact factor: 7.329

4.  Association between smoking cessation and sexual health in men.

Authors:  Christopher B Harte; Cindy M Meston
Journal:  BJU Int       Date:  2011-08-23       Impact factor: 5.588

5.  Confronting and coping with weight stigma: an investigation of overweight and obese adults.

Authors:  Rebecca M Puhl; Kelly D Brownell
Journal:  Obesity (Silver Spring)       Date:  2006-10       Impact factor: 5.002

6.  Testosterone concentrations in young pubertal and post-pubertal obese males.

Authors:  Muniza Mogri; Sandeep Dhindsa; Teresa Quattrin; Husam Ghanim; Paresh Dandona
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04       Impact factor: 3.478

Review 7.  Testosterone, body composition and aging.

Authors:  A Vermeulen; S Goemaere; J M Kaufman
Journal:  J Endocrinol Invest       Date:  1999       Impact factor: 4.256

8.  Selective serotonin reuptake inhibitor-induced sexual dysfunction.

Authors:  Giovanni Corona; Valdo Ricca; Elisa Bandini; Edoardo Mannucci; Francesco Lotti; Valentina Boddi; Giulia Rastrelli; Alessandra Sforza; Carlo Faravelli; Gianni Forti; Mario Maggi
Journal:  J Sex Med       Date:  2009-05       Impact factor: 3.802

9.  Health-related quality of life and quality of sexual life in obese subjects.

Authors:  Eleonora Poggiogalle; Luca Di Lazzaro; Alessandro Pinto; Silvia Migliaccio; Andrea Lenzi; Lorenzo M Donini
Journal:  Int J Endocrinol       Date:  2014-02-23       Impact factor: 3.257

10.  A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice.

Authors:  M P J Nicolai; S S Liem; S Both; R C M Pelger; H Putter; M J Schalij; H W Elzevier
Journal:  Neth Heart J       Date:  2014-01       Impact factor: 2.380

View more
  1 in total

1.  [Not Available].

Authors:  Alexandra Kautzky-Willer
Journal:  Wien Med Wochenschr       Date:  2016-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.